|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0494 USD | +90.00% |
|
+71.53% | +147.00% |
| Market Cap | 5.07M 3.61M 3.14M 2.93M 2.69M 344M 5.16M 34.52M 13.52M 172M 13.55M 13.25M 566M | P/E 2024 |
-6.82x | P/E 2025 | -2.84x |
|---|---|---|---|---|---|
| Enterprise Value | 9.47M 6.74M 5.86M 5.47M 5.02M 642M 9.63M 64.48M 25.25M 320M 25.31M 24.75M 1.06B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 0.85x |
| Free-Float |
89.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +90.00% | ||
| 1 week | +71.53% | ||
| 1 month | +52.00% | ||
| 3 months | -23.88% | ||
| 6 months | +394.00% | ||
| Current year | +147.00% |
| 1 week | 0.02 | 0.05 | |
| 1 month | 0.01 | 0.05 | |
| Current year | 0 | 0.07 | |
| 1 year | 0 | 0.07 | |
| 3 years | 0 | 0.16 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Taz Turner
CEO | Chief Executive Officer | - | 2017-09-21 |
Ashish Kapoor
DFI | Director of Finance/CFO | 48 | 2015-03-09 |
Graeme Hawkins
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Taz Turner
CHM | Chairman | - | 2018-05-16 |
Benjamin Higham
BRD | Director/Board Member | - | 2020-04-07 |
Jakob Ripshtein
BRD | Director/Board Member | 60 | 2020-04-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/23 | Buy | Director | 30,000 | 0.0274% | ||
| 12/17/23 | Buy | Director | 500 | 0.0005% | ||
| 12/17/23 | Buy | Director | 500 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +90.00% | +71.53% | +2.92% | -70.94% | 5.42M | ||
| +2.44% | +0.90% | +8.26% | +7.45% | 1.57B | ||
| +5.56% | -0.59% | +81.26% | +242.18% | 861M | ||
| -0.67% | -1.33% | -1.00% | +80.00% | 186M | ||
| -4.11% | -5.41% | +12.90% | -62.96% | 154M | ||
| +0.18% | -2.11% | +40.40% | -47.94% | 79.78M | ||
| Average | +15.57% | +9.60% | +24.12% | +24.63% | 476.72M | |
| Weighted average by Cap. | +2.93% | +0.54% | +30.78% | +77.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.8M 9.82M 8.54M 7.97M 7.32M 936M 14.04M 93.99M 36.81M 467M 36.9M 36.08M 1.54B | 14.25M 10.15M 8.82M 8.23M 7.56M 967M 14.5M 97.06M 38.02M 482M 38.11M 37.26M 1.59B |
| Net income | -1.49M -1.06M -924K -862K -792K -101M -1.52M -10.17M -3.98M -50.51M -3.99M -3.9M -167M | -2.69M -1.92M -1.66M -1.55M -1.43M -183M -2.74M -18.33M -7.18M -91.06M -7.2M -7.04M -300M |
| Net Debt | 5.66M 4.03M 3.5M 3.27M 3M 384M 5.76M 38.54M 15.1M 191M 15.13M 14.8M 632M | 4.4M 3.13M 2.72M 2.54M 2.33M 298M 4.47M 29.96M 11.73M 149M 11.76M 11.5M 491M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | US$0.0494 | +90.00% | 61,281 |
| 26-07-29 | US$0.0260 | -3.35% | 39,000 |
- Stock Market
- Stocks
- LVRLF Stock
Select your edition
All financial news and data tailored to specific country editions
















